Despite advances in imaging and pathology, positive margins remain one of the most persistent challenges in breast-conserving surgery.
Traditional imaging like X-ray, Ultrasound and CT are too low in resolution to visualize microscopic disease, resulting in cancer being missed at the margins of excised tissue or “positive margins.”
Claire was designed to change that.
To learn more about Claire
Contact Us
* US Food and Drug Administration. Claire OCT System - P250008. Premarket Approval (PMA) Approval Order. March 3, 2026. [Not yet published in PMA database]
* Perimeter Medical Imaging AI. Wide Field OCT + AI for Positive Margin Rates in Breast Conservation Surgery. Identification No NCT05113927. Last updated December 12, 2024. Available at: https://clinicaltrials.gov/study/NCT05113927.
Claire’s AI assistant, highlights regions suspicious for breast cancer directly within the OCT image—guiding attention, not dictating action.
AI overlays can be toggled ON, Show Less, or OFF
Highlights suspicious microstructural features associated with DCIS & IDC
Prioritized review with look-here assistance
Supports surgeon-led review
